Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Brainomix has raised $18.2M in total funding. The most recent round was Series C. The last funding was announced in March 2025.
Brainomix's investors include Tencent, Boehringer Ingelheim Venture Fund, Innovate UK, Parkwalk Advisors, EASME.
Brainomix is headquartered in Oxford, United Kingdom.
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Brainomix is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brainomix — Funding & Investors." VCBacked, March 18, 2025, https://www.vcbacked.co/company/brainomix. Accessed July 19, 2026.
VCBacked. (2025). Brainomix — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/brainomix
{{cite web |title=Brainomix — Funding & Investors |url=https://www.vcbacked.co/company/brainomix |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated